Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Randomized, Double Blind, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Riociguat in Scleroderma - Associated Digital Ulcers

NCT02915835 is registered in ClinicalTrials.gov with Dinesh Khanna, MD, MS as lead sponsor.

NCT NCT02915835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02915835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Randomized, Double Blind, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Riociguat in Scleroderma - Associated Digital Ulcers
Lead sponsor
Dinesh Khanna, MD, MS
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2016
Completion date
July 24, 2018
Enrollment
17 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

digital ulcers, scleroderma